Chunmei Cai

6PUBLICATIONS
2CO-AUTHORS
Molecular targetsPredictive and prognostic markersHaematological tumoursCancer cell biologyMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 27, 2026
Correction: Chai et al. Exploring Novel Therapeutic Targets in Breast Cancer via Comprehensive Omics Profiling and Experimental Verification. Biology 2025, 14, 405.

|Jan 08, 2026
Hypoxia promotes progression of cervical cancer by modulating the ATXN3-enhanced P53 stability or STAT5 phosphorylation.

Rong Zhang, Shengjun Chai, Fengjuan Zhang

|Oct 25, 2025
Association between antibody-mediated immune responses of herpesvirus and osteoporosis: Mendelian randomization study.

Botong Li, Shengjun Chai, Hong Wu

|Apr 26, 2025
Exploring Novel Therapeutic Targets in Breast Cancer via Comprehensive Omics Profiling and Experimental Verification.

Shengjun Chai, Jiayong Cui, Yinuo Sun

|Jan 11, 2025
Hypoxia Promotes Osteoclast Differentiation by Weakening USP18-Mediated Suppression on the NF-κB Signaling Pathway.

Xiaoxia Fan, Botong Li, Shengjun Chai

|Sep 05, 2020
A mathematic model to reveal delicate cross-regulation between MAVS/STING, inflammasome and MyD88-dependent type I interferon signalling.

Chunmei Cai, Xiao Yu

Pageof 1

Frequent Collaborators

2 joint publications

Shengjun Chai

1 joint publications

Xiao Yu